The European Society of Human Genetics heard about the real world advantages to diagnosis and healthcare costs on Sunday.
Elizabeth Holmes, Founder of disgraced biotech Theranos, and her former COO, Ramesh ‘Sunny’ Balwani, have been indicted with alleged wire fraud schemes in the state of California.
A large study has found that knowing your genetic risk for various diseases makes people switch to healthier lifestyles, and stick to them.
Digital health devices have become invaluable tools for improving human health. However, could a pill carrying an inbuilt sensor dehumanize patients, reducing them to a digital readout?
Scientists have made the first direct observation of a key step in the process that bacteria use to rapidly evolve new traits, including antibiotic resistance.
Non-profit Bill & Melinda Gates Medical Research Institute (MRI) has officially been launched, creating a new vision for drug development with a clear focus on the millions of people that die annually from contracting malaria, tuberculosis and diarrheal diseases.
A new blood test for pregnant women detects with 75-80% accuracy whether their pregnancies will end in premature birth. The technique can also be used to estimate a fetus’ gestational age — or the mother’s due date — as reliably as and less expensively than ultrasound.
Despite the availability of hepatitis C treatment and changes in restrictions of these therapies, private insurance companies and even public payers like Medicaid and Medicare are still refusing to pay for it.
Singapore could become the second country to legalise MRT but they are considering a new method that differs from the two currently legal in the UK.
A security breach at DNA testing website MyHeritage have leaked the data of over 92 million users, the company said on Monday.
A patient with metastatic breast cancer has made a dramatic recovery after receiving a personalised therapy using her own cells.
A 21-gene test performed on tumours could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study.
Whilst biotech companies are rushing to bring transformative gene therapies to market, states are too slow on adopting screening tests for genetic diseases that are, increasingly, treatable.